EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies

Findings from a major EU public-private project on how to use patient preference studies to better inform regulatory and reimbursement decision-making for drugs and medical devices holds promise for the delivery of improved outcomes for patients.

The results from the project, called PREFER, explain when and how it is best to perform patient preference studies and incorporate their outcomes in decision-making throughout the medical product lifecycle, especially during product development, regulatory evaluations and health technology assessments (HTAs)